Informations techniques
Exploitant
THERATECHNOLOGIES INTERNATIONAL LIMITED
Présentation
TROGARZO 200 mg/1,33 mL (ibalizumab), solution pour perfusion
2 flacons de 1,33 mL (CIP : 34009 589 018 9 8)
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
B6vHFCFRJWbVLVAL